Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous potassium chloride infusion rate comparison for correction of hypokalemia in critically ill patients
IRCT20141009019470N102Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of potassium chloride in hypokalemia (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Serum potassium level and Arrhythmia. Started Oct 2020; status: completed.
02
Drugs
potassium chloride
03
Conditions
hypokalemia
Beyond the preview
Go deeper on IRCT20141009019470N102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N102.